Informations

Stand number

C76

Exhibition class

M: Medicine – Surgery – Orthopaedics – Material for disabled

Technical description

Use of gamma-delta-T cell-derived extracellular vesicles as a versatile platform for cancer vaccine development. They simultaneously enhance immune activation and exert antitumor effects, providing a scalable, off-the-shelf solution for various cancers.

Simplified description

Scientists are developing a new cancer vaccine using tiny particles from specialized immune cells called gamma-delta-T cells. These particles boost the body's immune response and fight tumors, offering a ready-made and versatile treatment option for different types of cancer.